ONVATILIMAB

UNII:	1UI8F5IIZ4
Formula:
Preferred Substance Name:	ONVATILIMAB
GSRS Full Record:	1UI8F5IIZ4 i

1969313-51-6
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROTEIN VISTA (V-DOMAIN IMMUNOGLOBULIN SUPPRESSOR OF T CELL ACTIVATION)) (HUMAN CLONE JNJ 61610588 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN CLONE JNJ 61610588 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS V-TYPE IMMUNOGLOBULIN DOMAIN-CONTAINING SUPPRESSOR OF T-CELL ACTIVATION (PLATELET RECEPTOR GI24, SISP1))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-450) (HOMO SAPIENS VH (IGHV1-69*01 (IGHD)-IGHJ4*01) (8.8.13) (1-120) -HOMO SAPIENS IGHG1*03 (CH1(R97>K(217))) (121-450)) (223-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV1-39*01 (93%) IGKJ1*01)(6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214'))DIMER (229-229'':232-232'')-BISDISULFIDE
JNJ61610588
JNJ-61610588
ONVATILIMAB [INN]
ONVATILIMAB [USAN]
ONVATILIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ONVATILIMAB

Synonyms and Mappings

Resources